Hyperglycemia is common among hospitalized patients, affecting approximately 40% of patients at the time of hospital admission, despite the fact that 1 in every 8 patients has no previous diagnosis of diabetes. Hyperglycemia has been associated with poor patient outcomes, including higher rates of morbidity and mortality across a range of conditions. This review discusses options for the effective management of hyperglycemia with a focus on the use of disposable insulin pens in the hospital.
Methods
Literature, including guidelines for hospital management of hyperglycemia, and information regarding methods of insulin administration were reviewed
Results
Appropriate glucose control via administration of insulin within hospitals has been acknowledged as an important goal and is consistent with achieving patient safety. Insulin may be administered subcutaneously using a pen or vial and syringe or infused intravenously. Levels of patient and provider satisfaction are higher with pen administration than with vial and syringe. Insulin pens have many safety and convenience features including enhanced dose accuracy and autocover/autoshield pen needles.
Conclusion
Use of insulin pens instead of vials and syringes can provide several advantages for hospitalized patients, including greater satisfaction among them and health care providers, improved safety, and reduced costs. These advantages can continue following patient discharge.
American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596–615.
2.
SchmeltzLR. Safe insulin use in the hospital setting. Hosp Pract.2009;37(1):2009–2051.
3.
MoghissiES. Reexamining the evidence for inpatient glucose control: new recommendations for glycemic targets. Am J Health Syst Pharm.2010;67(16 suppl 8):S3–S8.
4.
UmpierrezGEIsaacsSDBazarganNYouXThalerLMKitabchiAE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab.2002;87(3):978–982.
5.
ClementSBraithwaiteSSMageeMF. Management of diabetes and hyperglycemia in hospitals. Diabetes Care.2004;27(2):553–591.
6.
CapesSEHuntDMalmbergKGersteinHC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet.2000;355(9206):773–778.
7.
CapesSEHuntDMalmbergKPathakPGersteinHC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke.2001;32(10):2426–2432.
8.
CandeliseLLandiGOrazioENBoccardiE.Prognostic significance of hyperglycemia in acute stroke. Arch Neurol.1985;42(7):661–663.
9.
KrinsleyJS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc.2003;78(12):1471–1478.
10.
GuvenerMPasaogluIDemircinMOcM.Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J.2002;49(5):531–537.
11.
FurnaryAPZerrKJGrunkemeierGLStarrA.Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg.1999;67(2):352–360.
12.
ThouraniVHWeintraubWSSteinB. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg.1999;67(4):1045–1052.
13.
WeintraubWSWengerNKJonesELCraverJMGuytonRA. Changing clinical characteristics of coronary surgery patients. Differences between men and women. Circulation.1993;88(5 pt 2):II-79-II-86.
14.
McConnellYJJohnsonPMPorterGA. Surgical site infections following colorectal surgery in patients with diabetes: association with postoperative hyperglycemia. J Gastrointest Surg.2009;13(3):508–515.
15.
MarchantMHJr.ViensNACookCVailTPBolognesiMP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am.2009;91(7):1621–1629.
16.
McAlisterFAMajumdarSRBlitzSRoweBHRomneyJMarrieTJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care.2005;28(4):810–815.
17.
BakerEHJanawayCHPhilipsBJ. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax.2006;61(4):284–289.
18.
FalcigliaMFreybergRWAlmenoffPLD'AlessioDARenderML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med.2009;37(12):3001–3009.
19.
MalmbergKRydenLEfendicS. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol.1995;26(1):57–65.
20.
Van den BergheGWoutersPWeekersF. Intensive insulin therapy in critically ill patients. N Engl J Med.2001;345(19):1359–1367.
21.
Van den BergheGWoutersPJKestelootKHillemanDE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med.2006;34(3):612–616.
22.
MalmbergKNorhammarAWedelHRydénL.Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes and acute myocardial infarction. Long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation.1999;99(20):2626–2632.
23.
FurnaryAPWuYBookinSO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract.2004;10(suppl 2):21–33.
24.
Van den BergheGWilmerAHermansG. Intensive insulin therapy in the medical ICU. N Engl J Med.2006;354(5):449–461.
25.
MoghissiESKorytkowskiMTDinardoM. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract.2009;15(4):353–369.
26.
FinferSChittockDRSuSY. Intensive versus conventional glucose control in critically ill patients. N Engl J Med.2009;360(13):1283–1297.
27.
CheungNWWongVWMcLeanM.The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care.2006;29(4):765–770.
28.
DevosPPreiserJCMelotC.Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intens Care Med.2007;33 (suppl 2):S189.
29.
PreiserJCDevosPRuiz-SantanaS. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intens Care Med.2009;35(10):1738–1748.
30.
BrunkhorstFMEngelCBloosF. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med.2008;358(2):125–139.
31.
La Rosa GdCDeDonadoJHRestrepoAH. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care.2008;12(5):R120.
32.
American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care.2011;34(suppl 1):S11–S61.
CookCBEliasBKongableGLPotterDJShepherdKMMcMahonD.Diabetes and hyperglycemia quality improvement efforts in hospitals in the United States: current status, practice variation, and barriers to implementation. Endocr Pract.2010;16(2):219–230.
35.
KellyJL. Ensuring optimal insulin utilization in the hospital setting: role of the pharmacist. Am J Health Syst Pharm.2010;67(16 suppl 8):S9–16.
36.
SchmeltzLRDeSantisAJSchmidtK. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract.2006;12(6):641–650.
37.
MoghissiES. Addressing hyperglycemia from hospital admission to discharge. Curr Med Res Opin.2010;26(3):589–598.
38.
ClementS.Better glycemia control in the hospital: beneficial and feasible. Cleveland Clin J Med.2007;74(2):111–120.
39.
BeckerTMoldoveanuACukiermanTGersteinHC. Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabetes Res Clin Pract.2007;78(3):392–397.
40.
UmpierrezGESmileyDZismanA. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care.2007;30(9):2181–2186.
41.
GoldsteinHH. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes. Postgrad Med.2008;120(3):172–179.
42.
DavisEMBebeeACrawfordLDestacheC.Nurse satisfaction using insulin pens in hospitalized patients. Diabetes Educ.2009;35(5):799–809.
43.
DavisEMChristensenCMNystromKKForalPADestacheC.Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm.2008;65(14):1347–1357.
44.
BohannonNJVOhannesianJPBurdanALHolcombeJHZagarA.Patient and physician satisfaction with the Humulin/Humalog pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther.2000;22(9):1049–1067.
45.
PeyrotMRubinRR. Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus. Curr Med Res Opin.2008;24(8):2413–2422.
46.
ShaghouliAAShahBR. The prescription of insulin pen devices versus syringes for older people with diabetes. Diabetes Technol Ther.2009;11(7):439–442.
47.
LowesLDavisR.A UK wide survey of insulin initiation in children with type 1 diabetes and nurses' perceptions of associated decision-making. J Clin Nurs.2009;18(9):1287–1294.
48.
McDowellJRCoatesVDavisR. Decision-making: initiating insulin therapy for adults with diabetes. J Adv Nurs.2009;65(1):35–44.
49.
CarterJRobertsA.Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia. Curr Med Res Opin.2008;24(10):2741–2749.
50.
MolifeCLeeLJShiLSawhneyMLenoxSM. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe. Diabetes Technol Ther.2009;11(8):529–538.
US Department of Health and Human Services. National Institute for Occupational Safety and Health Alert: preventing needlestick injuries in health care settings. http://www.cdc.gov/niosh/docs/2000-108/. Accessed November 27, 2012.
WardLGAtonSS. Impact of an interchange program to support use of insulin pens. Am J Health Syst Pharm.2011;68(14):1349–1352.
57.
PawaskarMDCamachoFTAndersonRTCobdenDJoshiAVBalkrishnanR.Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther.2007;29(spec no):1294–1305.
58.
LeeWCBaluSCobdenDJoshiAVPashosCL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther.2006;28(10):1712–1725.
59.
CobdenDLeeWCBaluSJoshiAVPashosCL. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Pharmacotherapy.2007;27(7):948–962.
